Euroimmun Us, Inc.: FDA clearances and approvals

Euroimmun Us, Inc. has 36 FDA 510(k) clearances (first 2006, latest 2020), plus 1 De Novo decision, across 21 product codes in 3 review panels. Median 510(k) review time: 268 days. Since 2017 its median was 268 days, against 167 days for all cleared 510(k)s in the same product codes.

510(k) clearances per year

YearClearancesMedian review days
20122406
20135237
20143314
20152282
20163268
2017190
20183268
2019191
20201310
20210—
20220—
20230—
20240—
20250—
20260—

Review time against the same product codes

Since 2017, Euroimmun Us, Inc.'s cleared 510(k)s took a median 268 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 167 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
MOBTest System, Antineutrophil Cytoplasmic Antibodies (Anca)55
DHNAntinuclear Antibody, Indirect Immunofluorescent, Antigen, Control33
LSRReagent, Borrelia Serological Reagent33
KTLAnti-Dna Indirect Immunofluorescent Solid Phase22
LKOAnti-Rnp Antibody, Antigen And Control22
MSTAntibodies, Gliadin22
MVMAutoantibodies, Endomysial(Tissue Transglutaminase)22
NIYAutoantibodies, Anti-Soluble Liver Antigen (Sla), Autoimmune Hepatitis22
NOPElisa, Antibody, West Nile Virus22
OEGAutoantibodies, Skin (Bullous Pemphigoid 180 And Bullous Pemphigoid 23022

Plus 11 more product codes.

Review panels

Most recent Euroimmun Us, Inc. 510(k) clearances

510(k)DeviceProduct codeDecision dateReview days
K193115EUROIMMUN Anti-BP230-CF ELISA (IgG)OEG2020-09-17310
K183313EUROIMMUN Anti-tissue Transglutaminase ELISA (IgA), EUROIMMUN Anti-tissue Transglutaminase ELISA (IgG)MVM2019-02-2891
K172582EUROIMMUN IFA Granulocyte Mosaic™ EUROPattern and EUROIMMUN EUROPLUS Granulocyte Mosaic™ EUROPatternMOB2018-05-24269
K172252EUROIMMUN IFA: Crithidia luciliae sensitive (anti-dsDNA) EUROPatternKTL2018-04-20268
K172244EUROIMMUN IFA: Crithidia luciliae (anti-dsDNA) EUROPatternKTL2018-04-20268
K172722Anti-Borrelia burgdorferi US EUROLINE-WB (IgM)LSR2017-12-1090
K161513Anti-Borrelia burgdorferi US Westernblot (IgG)LSR2016-08-2584
K153308EUROIMMUN Anti-West Nile Virus ELISA (IgM)NOP2016-08-12269
K153303EUROIMMUN Anti-West Nile Virus ELISA (IgG)NOP2016-08-10268
K142038EUROIMMUN LYME ELISA(IgG/IgM)LSR2015-05-04280

26 earlier clearances. See the full list in Caduvo.

PMA and De Novo decisions

NumberPathwayDeviceDecision date
DEN140002De NovoAnti-Phospholipase A2 Receptor2014-05-29

Recalls

openFDA lists no recalls under a recalling firm named Euroimmun Us, Inc..

Recalling firms are matched to this company by name only (same normalization as the applicant), so related entities that recall under another name are not counted.

Frequently asked questions

How many FDA 510(k) clearances does Euroimmun Us, Inc. have?

Euroimmun Us, Inc. has 36 FDA 510(k) clearances (first 2006, latest 2020), plus 1 De Novo decision, across 21 product codes in 3 review panels.

How long does FDA take to clear Euroimmun Us, Inc.'s 510(k)s?

The median time from FDA receipt to decision across Euroimmun Us, Inc.'s cleared 510(k)s is 268 days. Since 2017: 268 days, versus 167 days for all cleared 510(k)s in the same product codes.

What devices does Euroimmun Us, Inc. make?

Its most frequent FDA product codes are MOB (Test System, Antineutrophil Cytoplasmic Antibodies (Anca), 5); DHN (Antinuclear Antibody, Indirect Immunofluorescent, Antigen, Control, 3); LSR (Reagent, Borrelia Serological Reagent, 3).

Has Euroimmun Us, Inc. had device recalls?

openFDA lists no recalls under a recalling firm name matching Euroimmun Us, Inc. Related entities may recall under other names.

Next steps

Data from openFDA (510(k), PMA, De Novo, device recalls), ClinicalTrials.gov and SEC company tickers. Companies are grouped by FDA applicant name with punctuation and legal suffixes removed. Review days run from FDA receipt to decision. Not regulatory advice.

All FDA device companies · FDA product code lookup